Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

457 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research.
Espinosa Fernandez JR, Eckhardt BL, Lee J, Lim B, Pearson T, Seitz RS, Hout DR, Schweitzer BL, Nielsen TJ, Lawrence OR, Wang Y, Rao A, Ueno NT. Espinosa Fernandez JR, et al. Among authors: ueno nt. PLoS One. 2020 Apr 30;15(4):e0231953. doi: 10.1371/journal.pone.0231953. eCollection 2020. PLoS One. 2020. PMID: 32353087 Free PMC article.
Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer.
Iwamoto T, Bianchini G, Qi Y, Cristofanilli M, Lucci A, Woodward WA, Reuben JM, Matsuoka J, Gong Y, Krishnamurthy S, Valero V, Hortobagyi GN, Robertson F, Symmans WF, Pusztai L, Ueno NT. Iwamoto T, et al. Among authors: ueno nt. Breast Cancer Res Treat. 2011 Feb;125(3):785-95. doi: 10.1007/s10549-010-1280-6. Epub 2010 Dec 9. Breast Cancer Res Treat. 2011. PMID: 21153052 Free PMC article.
MEK1/2 inhibitor selumetinib (AZD6244) inhibits growth of ovarian clear cell carcinoma in a PEA-15-dependent manner in a mouse xenograft model.
Bartholomeusz C, Oishi T, Saso H, Akar U, Liu P, Kondo K, Kazansky A, Krishnamurthy S, Lee J, Esteva FJ, Kigawa J, Ueno NT. Bartholomeusz C, et al. Among authors: ueno nt. Mol Cancer Ther. 2012 Feb;11(2):360-9. doi: 10.1158/1535-7163.MCT-11-0400. Epub 2011 Dec 5. Mol Cancer Ther. 2012. PMID: 22144664 Free PMC article.
The antihelmintic drug pyrvinium pamoate targets aggressive breast cancer.
Xu W, Lacerda L, Debeb BG, Atkinson RL, Solley TN, Li L, Orton D, McMurray JS, Hang BI, Lee E, Klopp AH, Ueno NT, Reuben JM, Krishnamurthy S, Woodward WA. Xu W, et al. Among authors: ueno nt. PLoS One. 2013 Aug 27;8(8):e71508. doi: 10.1371/journal.pone.0071508. eCollection 2013. PLoS One. 2013. PMID: 24013655 Free PMC article.
Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers.
Masuda H, Baggerly KA, Wang Y, Iwamoto T, Brewer T, Pusztai L, Kai K, Kogawa T, Finetti P, Birnbaum D, Dirix L, Woodward WA, Reuben JM, Krishnamurthy S, Symmans W, Van Laere SJ, Bertucci F, Hortobagyi GN, Ueno NT. Masuda H, et al. Among authors: ueno nt. Breast Cancer Res. 2013 Nov 25;15(6):R112. doi: 10.1186/bcr3579. Breast Cancer Res. 2013. PMID: 24274653 Free PMC article.
High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer.
Anfossi S, Giordano A, Gao H, Cohen EN, Tin S, Wu Q, Garza RJ, Debeb BG, Alvarez RH, Valero V, Hortobagyi GN, Calin GA, Ueno NT, Woodward WA, Reuben JM. Anfossi S, et al. Among authors: ueno nt. PLoS One. 2014 Jan 8;9(1):e83113. doi: 10.1371/journal.pone.0083113. eCollection 2014. PLoS One. 2014. PMID: 24416156 Free PMC article.
457 results